Annual Conference linkedin

REGISTER NOW for our Annual Conference 2023, we are looking forward to welcoming you!

___________________________________________________________

Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia provides education, training and networking opportunities within and across each of the 4 domains it represents. 

Healixia events

  1. Scherm­afbeelding 2023-03-14 om 12.42.34.png
    23 May '23

    Healixia Conference: Deep Dive into BeNeLuxA

    Grimbergen

    There are 90 places available. ,

    Come and benchmark your current knowledge with actual insights and developments and receive practice advice, gain insight and discuss with peers about the challenges and opportunities.

Show all meetings

News

  1. March 28, 2023

    Reform of medicines reimbursement procedures by Riziv-Inami

    We werken aan een vernieuwend geneesmiddelenbeleid om een duurzame en toekomstbestendige toegankelijkheid van waardevolle farmaceutische specialiteiten voor patiënten in België te garanderen. Dit omvat een optimalisatie van de verschillende schakels voor alle betrokken stakeholders in het geneesmiddelenbeleid.

    Depuis 2022, nous sommes en train d’élaborer une politique innovante en matière de médicaments, dans le but de garantir aux patients un accès durable à des spécialités pharmaceutiques de qualité en Belgique. Il s‘agit notamment d’optimiser les différents « maillons » pour tous les intervenants impliqués dans la politique des médicaments.

    Source: Riziv-Inami

    Read more

  2. March 23, 2023

    Extension of transition period for the European Regulations for medical devices and for in-vitro diagnostics

    Vandaag besliste de Raad van Europa en het Europese Parlement om een langere overgangsperiode te voorzien om aangemelde instanties (notified bodies) en fabrikanten meer tijd te geven om medische hulpmiddelen te certificeren en zo het risico van tekorten te beperken zodat patiënten in nood toegang blijven houden tot medische hulpmiddelen.

    Aujourd'hui, le Conseil de l'Europe et le Parlement européen ont décidé de prévoir une période de transition plus longue afin de donner aux organismes notifiés (notified bodies) et aux fabricants plus de temps pour certifier les dispositifs médicaux, réduisant ainsi le risque de pénurie afin que les patients qui en ont besoin continuent d'avoir accès aux dispositifs médicaux.  

    Source: FAMHP

    Read more

  3. March 23, 2023

    New system for financing the surveillance of the medical devices market

    A new system for financing the surveillance of the medical devices market applies from 2023. This system aims to make fees fairer between the different stakeholders in the sector, as each one must pay a fee that is consistent with its turnover and with the level of risk involved in its activity and in the workload it represents for the FAMHP.  

    Source: FAMHP

    Read more

We thank our partners for their support:

AxTalis_reg access medical_scherm_transparent Brookwood Global-website Website Featured_JPG-IQVIA Logo - Tricolor jsn_logo_jj_vert_color_rgb QbD Group Logo_blue